Date mi v xa tt tn 3/2025
Monitoring your weight is valuable, but the scale can be stressful for a lot of folks
CrossRef Mapping the Impact of Glucagon-Like Peptide-1 Receptor Agonists on Aesthetic and Reconstructive Plastic Surgery: A Bibliometric Analysis of the 50 Most Cited Studies Edoardo Caimi, Emanuele Mark Ghetti, Federico Giovagnoli, Stefano Vaccari, Gianmaria Ceglia, Mattia Federico Cavallero, Roberta Comunian, Riccardo Di Giuli, Alessandra Veronesi, Francesco Klinger, Valeriano Vinci Aesthetic Plastic Surgery.2026;[Epub] CrossRef Response to comment on Efficacy and safety of GLP-1 receptor agonists in the management of obstructive sleep apnea in individuals without diabetes: A systematic review and meta-analysis of randomized, placebo-controlled trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam Sleep Medicine.2025
Carducci C, Birarelli M, Santagata P, Leuzzi V, Carducci C, Antonozzi I
Meaningful weight loss typically begins appearing on the scale during this window, with realistic expectations of 12 pounds per week for most patients
Administered via intramuscular or subcutaneous injection